BIOMAT Database Logo BIOMAT Database Logo

Clinical and pharmacological studies with 2',3',5'-triacetyl-6-azauridine. 1963

W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D001380 Azauridine A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic. 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione,6-Azauridine,6 Azauridine

Related Publications

W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
Hydrolysis of the prodrug, 2',3',5'-triacetyl-6-azauridine.
September 1995, Pharmaceutical research,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
In vitro metabolism studies of the prodrug, 2',3',5'-triacetyl-6-azauridine, utilizing an automated analytical system.
December 2001, Journal of pharmaceutical and biomedical analysis,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey.
September 1970, American journal of obstetrics and gynecology,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
Azaribine (triacetyl-6-azauridine) in psoriasis. Screening by in vitro methods.
December 1977, Archives for dermatological research = Archiv fur dermatologische Forschung,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
THE EFFECT OF TRIACETYL AZAURIDINE ON PSORIASIS.
December 1964, The Journal of investigative dermatology,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
The antifertility effect of 2', 3', 5'tri-O-acetyl-6-azauridine. I.
October 1969, The Indian journal of medical research,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
Catabolism of 2',3',5'-tri-O-acetyl-6-azauridine in human organism.
January 1966, Neoplasma,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2'-DEOXYURIDINE, AND RELATED DERIVATIVES.
September 1963, Cancer research,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine.
May 1963, Cancer research,
W A CREASEY, and M E FINK, and R E HANDSCHUMACHER, and P CALABRESI
Studies on 6-azauridine and 6-azacytidine. I. Toxicity studies of 6-azauridine and 6-azacytidine in mice.
November 1965, Biochemical pharmacology,
Copied contents to your clipboard!